Congratulations to the winners of this year’s Clinical Lasker Award: Charlie Rice of Rockefeller University
Ralf Bartenschlager of the University of Heidelberg
Michael Sofia of Arbutus Biopharma.
Dr. Tom Hobman received $ 1 Million from the CIHR Project scheme for his research on the Zika virus
World Hepatitis Day: Drs. Tyrrell and Houghton interviewed for the Edmonton Journal
SOSCIP and the University of Alberta’s Li Ka Shing Institute of Virology partner to leverage high-performance computing technologies and expertise
full Press Release story
Li Ka Shing Institute of Virology Principal Investigator Dr. Tom Hobman
at the frontline of research with Zika Virus
see articles and interviews
The Li Ka Shing Institute of Virology was created in 2010 through the combined gifts of $25-million from the Li Ka Shing (Canada) Foundation and $52.5-million from the Government of Alberta.
Take our Virtual Tour
Leading the world in virology discoveries and cures.
Through leadership in scientific excellence and international collaboration, the Li Ka Shing Institute of Virology will invest in virology research to discover new methods to prevent, treat and cure virus-related disease to reduce the burden of viral disease around the world.
The Li Ka Shing Institute of Virology (LKSIoV) unites a consortium of researchers to support discoveries in vaccines, treatments, and diagnostic tests for viral diseases affecting humans. the Institute builds on internationally recognized virology expertise and infrastructure with global connections to such partners as the US National Institutes of Health, the Bill and Melinda Gates Foundation and more.